High Court to Decide if Genes Can Be Patented

, The Litigation Daily


The U.S. Supreme Court granted certiorari Friday in Association for Molecular Pathology v. Myriad Genetics, on the specific question, "Are human genes patentable?" Given the court had already asked the U.S. Court of Appeals for the Federal Circuit to reconsider the question, and the Federal Circuit had stuck with its original answer of "yes," IP lawyers could see some handwriting on the wall.

This article has been archived, and is no longer available on this website.

View this content exclusively through LexisAdvance® Here

Not a LexisAdvance® Subscriber?

Subscribe Now

LexisAdvance® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisAdvance® customers will be able to access and use ALM's content by subscribing to the LexisAdvance® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Legaltech News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisAdvance® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202579992695

Thank you!

This article's comments will be reviewed.